×
For best experience we recommend to activate Javascript in your browser.
GFRA1 antibody (AA 239-350)
The Rabbit Polyclonal anti-GFRA1 antibody has been validated for WB, IHC, IP and ICC. It is suitable to detect GFRA1 in samples from Mouse.
Quick Overview for GFRA1 antibody (AA 239-350) (ABIN7618119)
Target
See all GFRA1 Antibodies
GFRA1
(GDNF Family Receptor alpha 1 (GFRA1))
Reactivity
All reactivities for GFRA1 antibodies
Mouse
Host
All hosts for GFRA1 antibodies
Rabbit
Clonality
All clonalities for GFRA1 antibodies
Polyclonal
Conjugate
All conjugates for GFRA1 antibodies
This GFRA1 antibody is un-conjugated
Application
All applications for GFRA1 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Product Details anti-GFRA1 Antibody
(hide)
Binding Specificity
All epitopes for GFRA1 antibodies
AA 239-350
Purpose
Glial Cell Line Derived Neurotrophic Factor Receptor Alpha 1 (GFRa1) Polyclonal Antibody
Sequence
Glu239~Asp350
Characteristics
The Glial Cell Line Derived Neurotrophic Factor Receptor Alpha 1 (GFRa1) Polyclonal Antibody (Species: Mouse) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for GFRA1
(hide)
Target
GFRA1
(GDNF Family Receptor alpha 1 (GFRA1))
Alternative Name
GFRa1
Gene ID
14585
UniProt
P97785
Recently viewed
(hide)
Chat with us , powered by LiveChat